<VariationArchive VariationID="1071347" VariationName="NM_001167.4(XIAP):c.1012dup (p.Tyr338fs)" VariationType="Duplication" Accession="VCV001071347" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1065156" VariationID="1071347">
      <GeneList>
        <Gene Symbol="XIAP" FullName="X-linked inhibitor of apoptosis" GeneID="331" HGNC_ID="HGNC:592" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq25</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="123859708" stop="123913972" display_start="123859708" display_stop="123913972" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="122993661" stop="123047828" display_start="122993661" display_stop="123047828" Strand="+" />
          </Location>
          <OMIM>300079</OMIM>
          <Haploinsufficiency last_evaluated="2022-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=XIAP">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=XIAP">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001167.4(XIAP):c.1012dup (p.Tyr338fs)</Name>
      <CanonicalSPDI>NC_000023.11:123891271:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq25</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="123891271" stop="123891272" display_start="123891271" display_stop="123891272" variantLength="1" positionVCF="123891271" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="123025121" stop="123025122" display_start="123025121" display_stop="123025122" variantLength="1" positionVCF="123025121" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>Y338fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.123025122dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.123025122dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001204401.2" sequenceAccession="NM_001204401" sequenceVersion="2" change="c.1012dup">
            <Expression>NM_001204401.2:c.1012dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001191330.1" sequenceAccession="NP_001191330" sequenceVersion="1" change="p.Tyr338fs">
            <Expression>NP_001191330.1:p.Tyr338fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378590.1" sequenceAccession="NM_001378590" sequenceVersion="1" change="c.1012dup">
            <Expression>NM_001378590.1:c.1012dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365519.1" sequenceAccession="NP_001365519" sequenceVersion="1" change="p.Tyr338fs">
            <Expression>NP_001365519.1:p.Tyr338fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378591.1" sequenceAccession="NM_001378591" sequenceVersion="1" change="c.1012dup">
            <Expression>NM_001378591.1:c.1012dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365520.1" sequenceAccession="NP_001365520" sequenceVersion="1" change="p.Tyr338fs">
            <Expression>NP_001365520.1:p.Tyr338fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001378592.1" sequenceAccession="NM_001378592" sequenceVersion="1" change="c.1012dup">
            <Expression>NM_001378592.1:c.1012dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001365521.1" sequenceAccession="NP_001365521" sequenceVersion="1" change="p.Tyr338fs">
            <Expression>NP_001365521.1:p.Tyr338fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_037916.2" sequenceAccession="NR_037916" sequenceVersion="2" change="n.376dup">
            <Expression>NR_037916.2:n.376dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_165803.1" sequenceAccession="NR_165803" sequenceVersion="1" change="n.358dup">
            <Expression>NR_165803.1:n.358dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.123891272dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.123891272dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007264.1" sequenceAccession="NG_007264" sequenceVersion="1" change="g.36075dup">
            <Expression>NG_007264.1:g.36075dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167.4" sequenceAccession="NM_001167" sequenceVersion="4" change="c.1012dup" MANESelect="true">
            <Expression>NM_001167.4:c.1012dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158.2" sequenceAccession="NP_001158" sequenceVersion="2" change="p.Tyr338fs">
            <Expression>NP_001158.2:p.Tyr338fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_19" sequenceAccession="LRG_19">
            <Expression>LRG_19:g.36075dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2148096182" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001167.4(XIAP):c.1012dup (p.Tyr338fs) AND X-linked lymphoproliferative disease due to XIAP deficiency" Accession="RCV001383799" Version="4">
        <ClassifiedConditionList TraitSetID="3179">
          <ClassifiedCondition DB="MedGen" ID="C1845076">X-linked lymphoproliferative disease due to XIAP deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-08-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-08-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17080092</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21119115</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25666262</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3179" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2711" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked lymphoproliferative disease due to XIAP deficiency</ElementValue>
                <XRef ID="MONDO:0010385" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lymphoproliferative syndrome 2, X-linked</ElementValue>
                <XRef ID="X-linked+lymphoproliferative+syndrome+2/9494" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XIAP DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="300635" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XLP2</ElementValue>
                <XRef Type="MIM" ID="300635" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">X-linked lymphoproliferative disease (XLP) has two recognizable subtypes, XLP1 and XLP2. XLP1 is characterized predominantly by one of three commonly recognized phenotypes: Inappropriate immune response to Epstein-Barr virus (EBV) infection leading to hemophagocytic lymphohistiocytosis (HLH) or severe mononucleosis. Dysgammaglobulinemia. Lymphoproliferative disease (malignant lymphoma). XLP2 is most often characterized by HLH (often associated with EBV), dysgammaglobulinemia, and inflammatory bowel disease. HLH resulting from EBV infection is associated with an unregulated and exaggerated immune response with widespread proliferation of cytotoxic T cells, EBV-infected B cells, and macrophages. Dysgammaglobulinemia is typically hypogammaglobulinemia of one or more immunoglobulin subclasses. The malignant lymphomas are typically B-cell lymphomas, non-Hodgkin type, often extranodal, and in particular involving the intestine.</Attribute>
                <XRef ID="NBK1406" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10916" />
                <XRef ID="10916" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">XIAP-Related Lymphoproliferative Disease, X-Linked</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301580</ID>
                <ID Source="BookShelf">NBK1406</ID>
              </Citation>
              <XRef ID="2442" DB="Orphanet" />
              <XRef ID="538934" DB="Orphanet" />
              <XRef ID="C1845076" DB="MedGen" />
              <XRef ID="MONDO:0010385" DB="MONDO" />
              <XRef Type="MIM" ID="300635" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3108699" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="11652794|MedGen:C1845076" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001583066" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17080092</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21119115</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25666262</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals with XIAP-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Tyr338Leufs*12) in the XIAP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XIAP are known to be pathogenic (PMID: 17080092, 21119115, 25666262). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XIAP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.123025121_123025122insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845076" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3108699" TraitType="Disease" MappingType="XRef" MappingValue="C1845076" MappingRef="MedGen">
        <MedGen CUI="C1845076" Name="X-linked lymphoproliferative disease due to XIAP deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

